Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients

NCT ID: NCT03920735

Last Updated: 2019-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-15

Study Completion Date

2019-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The analysis of a cohort of consecutive non-selected patients from the Strasbourg University Hospital, and therefore representative of the real life, will allow better identifying the risk factors for these infections (by comparison with a cohort of patient with similar conditions of immunosuppression and no infection) and improving the diagnosis and therapeutic management.

The primary objective is to identify prognosis factors affecting survival in patients with opportunistic infections

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematologic Disease Neoplams Transplantation Immunologic Deficiency Syndromes Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Opportunistic infection

Immunocompromised or frail patients with an opportunistic infection

No interventions assigned to this group

Control group

Immunocompromised or frail patients with no opportunistic infection

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non selected consecutive immunocompromised or frail patients with an opportunistic infection
* Hospitalized in any of the department of the University Hospital of Strasbourg
* For epidemiological study, patients with similar immunodepression of frail condition and no opportunistic infection

Exclusion Criteria

\- Opposition of the patient to use his personal data
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raoul HERBRECHT, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Strasbourg, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital, Strasbourg, france

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Raoul HERBRECHT, MD

Role: CONTACT

03 88 12 83 79 ext. 0033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Raoul HERBRECHT, MD

Role: primary

03 88 12 83 79 ext. 0033

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1INFOPP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RETR(Osteomyelitis)
NCT04936958 UNKNOWN